癌变·畸变·突变 ›› 2001, Vol. 13 ›› Issue (2): 81-085.doi: 10.3969/j.issn.1004-616x.2001.02.005

• 论著 • 上一篇    下一篇

珍香胶囊对裸鼠原位移植的人胃癌的抗癌作用

许锦阶1 ,徐小虎1 ,杨善民2 ,陈 福2   

  1. 1. 汕头大学医学院病理学和病理生理学系, 广东 汕头 515031; 21 厦门大学抗癌研究中心, 福建 厦门 361005
  • 收稿日期:2000-06-08 修回日期:2000-09-22 出版日期:2001-04-30 发布日期:2001-04-30

XU Jin-jie1, XU Xiao-hu1, YANG Shan-ming2, CHEN Fu2   

  1. 1. Department of Pathology and Pathophysiology, Shantou University Medical College, Shantou 515031, China; 2. Anti-cancer Research Center of Xiamen University, Xiamen  361005, China
  • Received:2000-06-08 Revised:2000-09-22 Online:2001-04-30 Published:2001-04-30

摘要: 目的:了解珍香胶囊对裸鼠原位移植的人胃癌的疗效,为临床试验提供科学依据。方法:用珍香胶囊分别对人胃低分化腺癌SGC27901 以及人胃高分化腺癌MKN228 裸鼠原位移植模型进行治疗。实验分5 组:珍香胶囊高浓度组(4 800 mg/ kg·bw) 、中浓度组(2 400 mg/ kg·bw) 、低浓度组(1 200 mg/ kg·bw) 以及阳性对照组(丝裂霉素C 1 mg/ kg·bw) 和阴性对照组(生理盐水) 。珍香胶囊灌胃给药,每天2 次,连续给药40 次,丝裂霉素C 皮下注射给药,每2 天1 次,共给药10 次。实验以荷人胃癌裸鼠的生命延长率、胃指数、血清唾液酸(SA) 含量作为疗效评价指标。实验重复3 次。结果: ①珍香胶囊高、中、低三剂量对荷人胃癌SGC27901 裸鼠生命延长率分别为57. 78 %~72. 03 %( P < 0. 01) ,42. 22 %~56. 59 %( P < 0. 01) 、28. 13 %~33. 79 %( P < 0. 01) ,阳性对照丝裂霉素C 对荷人胃癌SGC27901 裸鼠生命延长率为52. 58 %~60. 02 %( P < 0. 01) ; ②经珍香胶囊高、中剂量治疗后,荷人胃癌MKN228 裸鼠的胃指数、血清SA 含量显著减少( P < 0. 01 或P < 0. 05) 。结论:在裸鼠可耐受的剂量下,珍香胶囊对裸鼠原位移植的人胃低分化腺癌SGC27901 以及人胃高分化腺癌MKN228 均有明显的抗癌作用,且随着剂量增加,其抗癌疗效增强。

关键词: 珍香胶囊, 胃癌, 动物疾病模型, 裸鼠

Abstract: Purpose : The antitumor effect of Zhenxiang capsule (ZXC) was studied on the human stomach cancer xenot ransplanted orthotopically in nude mice in order to provide scientific evidence supporting for clinical use. Methods : A t reatment was carried out with ZXC on the nude mice orthotopically transplanted model of human stomach poor2differentiated adenocarcinoma SGC27901 and the human well2differentiated adenocarcinoma MKN228. The animals were divided into 5 groups : the high2dose group of ZXC with a dose of 4 800 mg/ kg·bw , the medium-dose group of ZXC with a dose of 2 400 mg/ kg·bw , and the low2dose group with a dose of 1 200 mg/kg·bw , the positive cont rol group of mitomycin C with a dose of 1 mg/ kg·bw , and the negative cont rol group with normal saline. The ZXC was perfused into the mouse stomachs twice daily , 40 times altogether. The mitomycin C was administ rated by hypodermic injection once every two days , 10 times altogether. The efficacy estimation indices of the test included the life2prolonging rate , stomach index , sialic acid (SA) content of serum of the nude mice with human stomach carcinoma. The test was repeated 3 times. Results : ①In the ZXC high medium and low dose group , the life2prolonging rate of the nude mice with human stomach carcinoma SGC27901 were 57. 78 % to 72. 03 %( P < 0. 01) , 42. 22 % to 56. 59 %( P < 0. 01) , and 28. 13 % to 33. 79 %( P < 0.01) , respectively. In the positive cont rol group of mitomycin C , the rate was f rom 52. 58 % to 60. 62 % ( P <0. 01) . ②After the administ ration of the high and medium dose of ZXC , the stomach index and the SA content of serum of the nude mice with human stomach carcinoma MKN228 were all significantly reduced respectively ( P < 0. 01) or P < 0. 05) . Conclusion : The ZXC had remarkable anti2cancer effect both on the nude mice orthotopic t ransplantation of the human stomach , poor differentiated adenocarcinoma SGC27901 and the well-differentiated adenocarcinoma MKN228. Under the tolerant dose of nude mice , the effect was improved with the increase in doses.

Key words: Zhenxiang capsule (ZXC), stomach cancer, animal disease models, nude mice

中图分类号: